Finance

Lists
600085:SHA
Beijing Tong Ren Tang Co Ltd
24,76 CN¥
+0,41%
(+0,10) 1D
15 հոկ, 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600085...
Open
24,52 CN¥
High
24,90 CN¥
Low
24,43 CN¥
Mkt. cap
33,45 մլրդ
Avg. vol.
4,48 մլն
Volume
9,96 մլն
Dividend
2,02%
Quarterly dividend
0,12 CN¥
Ex-dividend date
01 հլս, 2026 թ.
P/E ratio
35,01
52-wk high
35,87 CN¥
52-wk low
21,87 CN¥
EPS
0,71 CN¥
Shares outstanding
1,37 մլրդ
No. of employees
17 հզր
Open
24,52 CN¥
High
24,90 CN¥
Low
24,43 CN¥
Mkt. cap
33,45 մլրդ
Avg. vol.
4,48 մլն
Volume
9,96 մլն
Dividend
2,02%
Quarterly dividend
0,12 CN¥
Ex-dividend date
01 հլս, 2026 թ.
P/E ratio
35,01
52-wk high
35,87 CN¥
52-wk low
21,87 CN¥
EPS
0,71 CN¥
Shares outstanding
1,37 մլրդ
No. of employees
17 հզր
News stories
From web sources and news partners
Profile
Tong Ren Tang is a Chinese pharmaceutical company founded in 1669. It is now the largest producer of traditional Chinese medicine. The company headquarters are in Beijing, where they engage in both manufacturing and retail sales. It operates drug stores, predominantly in Chinese-speaking regions. Tong Ren Tang is considered one of the "Big 4" traditional Chinese medicine brands still in existence. The four companies include: Guangyuyuan, Guangzhou Chen Liji, Beijing Tong Ren Tang, and Hangzhou Hu Qing Yu Tang. Tong Ren Tang, and GuangYuYuan have been officially recognized as "China Time-Honored Brands" by the Ministry of Commerce of the People's Republic of China. Wikipedia
About Beijing Tong Ren Tang Co Ltd
CEO-
Employees17,3 հզր
Founded1669
Headquarters-
Sector-
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
2026 թ. հնս
Revenue
3,54 մլրդ
3,95 մլրդ
4,66 մլրդ
3,72 մլրդ
Cost of goods sold
1,97 մլրդ
2,50 մլրդ
2,72 մլրդ
2,17 մլրդ
Cost of revenue
1,97 մլրդ
2,50 մլրդ
2,72 մլրդ
2,17 մլրդ
Research and development expenses
53,41 մլն
144,52 մլն
51,64 մլն
74,50 մլն
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,10 մլրդ
1,30 մլրդ
1,13 մլրդ
1,04 մլրդ
Operating expense
1,16 մլրդ
1,52 մլրդ
1,23 մլրդ
1,16 մլրդ
Total operating expenses
3,13 մլրդ
4,02 մլրդ
3,95 մլրդ
3,33 մլրդ
Operating income
408,67 մլն
-73,33 մլն
709,73 մլն
383,76 մլն
Other non operating income
-3,64 մլն
-4,50 մլն
-3,96 մլն
-4,53 մլն
EBT including unusual items
346,57 մլն
67,54 մլն
748,37 մլն
431,21 մլն
EBT excluding unusual items
418,62 մլն
-56,72 մլն
750,60 մլն
414,06 մլն
Income tax expense
88,79 մլն
27,32 մլն
131,64 մլն
112,60 մլն
Effective tax rate
25,62%
40,44%
17,59%
26,11%
Other operating expenses
-1,80 մլն
58,15 մլն
29,98 մլն
47,32 մլն
Net income
232,06 մլն
11,82 մլն
471,18 մլն
255,01 մլն
Net profit margin
6,56%
0,30%
10,10%
6,86%
Earnings per share
-
-
-
-
Interest and investment income
45,55 մլն
48,93 մլն
70,91 մլն
59,45 մլն
Interest expense
-30,03 մլն
-28,19 մլն
-26,08 մլն
-24,57 մլն
Net interest expenses
15,52 մլն
20,74 մլն
44,83 մլն
34,88 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
495,57 մլն
18,15 մլն
801,21 մլն
477,52 մլն
Gain or loss from assets sale
1,87 մլն
-25,11 մլն
-
-10,41 մլն
AI content may include mistakes. Learn more
Google Apps